<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Bryce Foster | Roberts Baker | Activity</title>
	<link>https://brycefoster.com/members/canroot6/activity/</link>
	<atom:link href="https://brycefoster.com/members/canroot6/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Roberts Baker.</description>
	<lastBuildDate>Sat, 09 May 2026 21:11:41 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">f9d3f0706b904cc95265076575d2e2cd</guid>
				<title>Roberts Baker posted an update: Understanding the Ozempic Supply Situation in Russia



In [&#133;]</title>
				<link>https://brycefoster.com/activity/p/1358422/</link>
				<pubDate>Fri, 06 Mar 2026 09:04:48 +0000</pubDate>

									<content:encoded><![CDATA[<p>Understanding the Ozempic Supply Situation in Russia</p>
<p>In the last few years, Ozempic (semaglutide) has actually emerged as an innovative medication utilized primarily for the management of type 2 diabetes and, more just recently, for weight-loss. Its popularity, nevertheless, has actually caused substantial supply obstacles in different parts of&hellip;<span class="activity-read-more" id="activity-read-more-1358422"><a href="https://brycefoster.com/activity/p/1358422/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">df0b5304091453c4cd644250d5d5cf4d</guid>
				<title>Roberts Baker became a registered member</title>
				<link>https://brycefoster.com/activity/p/1358144/</link>
				<pubDate>Fri, 06 Mar 2026 08:09:35 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>